Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-30

FDA Approved: CEVIMELINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' cevimeline hydrochloride under an original application for the treatment of dry mouth due to Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)